With anywhere from an estimated 7.7 to 23 million people living in America struggling with long COVID, the U.S. Department of Health and Human Services (HHS) launched the Office of Long COVID Research and Practice to lead a Long COVID response and coordination across the federal government. In parallel the National Institutes of Health (NIH) launched a program of Long COVID trials via the RECOVER Initiative.
The news came via announcement by HHS Secretary Xavier Becerra who has been under mounting pressure to mobilize American resources to deal with the crisis. With a paucity of research findings and little direction in the front line, the COVID-19 pandemic emergency triggered a top down, federalized approach to medicine, which isn’t the way health care really works in America.
Typically, the system is far more decentralized, with physician groups afforded considerable flexibility to determine clinical solutions with of course federal processes such as drug approvals, research funding via the NIH and national public health guidance via the Centers for Disease Control and Prevention.
------------------------------------
Join The Conversation! | https://trialsitenews.com/
11:33
8:59
11:57
10:05
10:05
9:59
9:53
